Published in Thromb Res on December 16, 2009
Acquired antiprothrombin antibodies: an unusual cause of bleeding. BMJ Case Rep (2013) 0.75
Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood (1997) 2.75
Chemolithoautotrophic metabolism of anaerobic extremely thermophilic archaebacteria. Nature (1983) 2.38
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost (1992) 2.31
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1997) 2.18
Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost (1994) 1.96
Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med (1994) 1.85
Escherichia coli genes required for cytochrome c maturation. J Bacteriol (1995) 1.77
Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol (1995) 1.76
Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care (1983) 1.69
The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol (1996) 1.64
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines. J Lab Clin Med (1996) 1.39
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation (1997) 1.28
Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract (2001) 1.28
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet (1996) 1.20
Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med (1999) 1.19
Laparoscopic colectomy for recurrent and complicated diverticulitis: a prospective study of 396 patients. Langenbecks Arch Surg (2004) 1.16
High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol (1998) 1.01
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol (1999) 1.00
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood (2001) 1.00
Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience. AIDS (1997) 0.98
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1998) 0.98
Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost (1997) 0.97
Soluble thrombomodulin as predictor of incident coronary heart disease. Lancet (1999) 0.96
Some chemical and stereochemical modifications of the erythromycin lactone rings. J Org Chem (1974) 0.96
Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol (1999) 0.95
Cardiovagal modulation upon postural change is altered in Huntington's disease. Eur J Neurol (2008) 0.95
Guidelines for cost-effective implementation of Picture Archiving and Communication Systems. An approach building on practical experiences in three European hospitals. Int J Biomed Comput (1996) 0.93
Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. J Exp Med (1994) 0.93
Rifabutin for experimental pneumococcal meningitis. Chemotherapy (1997) 0.93
A new method for the estimation of protein C by ELISA. Thromb Res (1984) 0.92
Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease. Br J Haematol (1996) 0.91
New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides. Blood (1998) 0.91
Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum (1994) 0.91
[Prolonged ACTH and cortisone therapy of chronic polyarthritis]. Ugeskr Laeger (1953) 0.90
Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolism. Am J Respir Crit Care Med (1998) 0.90
Comparative in-vitro validation of eight first- and second-generation quantitative coronary angiography systems. Coron Artery Dis (1997) 0.90
A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody binding. J Biol Chem (1988) 0.89
Morphometric analysis of basal laminae in rats with long-term streptozotocin diabetes L. II. Retinal capillaries. Exp Eye Res (1983) 0.89
Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa (1998) 0.89
Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost (1998) 0.89
Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA. Thromb Haemost (2000) 0.89
Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat. Anat Rec (1999) 0.88
Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg (1993) 0.87
A splice variant of beta-secretase deficient in the amyloidogenic processing of the amyloid precursor protein. J Biol Chem (2001) 0.87
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Am J Cardiol (2000) 0.87
A DNA library from an individual Beta patellaris chromosome conferring nematode resistance obtained by microdissection of meiotic metaphase chromosomes. Plant Mol Biol (1992) 0.87
Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy. Thromb Haemost (1985) 0.87
Preoperative screening for von Willebrand disease type 1: low yield and limited ability to predict bleeding. J Lab Clin Med (1999) 0.86
Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment. Histochem Cell Biol (2009) 0.85
Growth-factor-independent proliferation in vitro and tumorigenicity in vivo are associated in basophil/mast-cell lines and their somatic hybrids. Differentiation (1985) 0.85
Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion (1994) 0.85
Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma. J Lab Clin Med (1996) 0.85
[Spontaneous regression of diabetic retinopathy (author's transl)]. Klin Monbl Augenheilkd (1976) 0.84
Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res (1993) 0.84
Mechanism of action of aldosterone on potassium transfer in the rat kidney. Pflugers Arch (1973) 0.84
Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium. Br J Haematol (1997) 0.84
Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol (1997) 0.84
[Comparison of medium-term clinical and radiological outcome between cemented and cementless medial unicompartmental knee arthroplasty]. Z Orthop Unfall (2009) 0.83
In-hospital mortality of elderly patients with acute myocardial infarction: data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry. Clin Cardiol (2000) 0.83
[Phosphoenolpyruvate as substrate of alkaline phosphatase: competition with pyruvate kinase]. Hoppe Seylers Z Physiol Chem (1965) 0.83
Effect of pH on potential difference and short circuit current in the isolated human cornea. Pflugers Arch (1974) 0.83
Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies. Eur J Clin Invest (1998) 0.83
Soluble adhesion molecules, endothelial markers and atherosclerosis risk factors in abdominal aortic aneurysm: a comparison with claudicants and healthy controls. Blood Coagul Fibrinolysis (1998) 0.82
[Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss]. Rev Med Interne (1999) 0.82
Quantification of the selective retention of palladium octabutoxynaphthalocyanine, a potential photothermal drug, in mouse tissues. J Photochem Photobiol B (2000) 0.82
An enzyme immunoassay (ELISA) for the quantitation of human factor VII. Thromb Haemost (1986) 0.82
Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis (Liatest D-dimer). Am J Clin Pathol (1998) 0.82
Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls. Atherosclerosis (2000) 0.82
Potential difference and short-circuit current in isolated human cornea. Pflugers Arch (1972) 0.82
Elevated thrombomodulin plasma levels as a result of endothelial involvement in plasmodium falciparum malaria. Thromb Haemost (1994) 0.82
[Diabetes and kidneys]. Dtsch Med Wochenschr (2013) 0.82
[Long-term outcome of AV node modulation in 387 consecutive patients with AV nodal reentrant tachycardia]. Z Kardiol (2002) 0.82
Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in man. Eur J Clin Invest (1991) 0.81
The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost (1999) 0.81
Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant (1996) 0.81
The results of "exercise therapy in coronary prone individuals and coronary patients". G Ital Cardiol (1976) 0.81
Thrombospondin (TSP1) mediates in vitro proliferation of human MG-63 osteoblastic cells induced by alpha-thrombin. FEBS Lett (1993) 0.81
[Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries]. Z Kardiol (2002) 0.80
Characterization of fibrillar collagen types using multi-dimensional multiphoton laser scanning microscopy. Int J Cosmet Sci (2012) 0.80
Is post-mortem CT of the dentition adequate for correct forensic identification?: comparison of dental computed tomograpy and visual dental record. Int J Legal Med (2008) 0.80
Morphometric analysis of basal laminae in rats with long-term streptozotocin diabetes. I. Vitreoretinal juncture. Exp Eye Res (1982) 0.80
Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1. Biochem J (1997) 0.80
[Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany]. Z Kardiol (1999) 0.80
Diagnostic value of a new sensitive membrane based technique for instantaneous D-dimer evaluation in patients with clinically suspected deep venous thrombosis. Thromb Haemost (1997) 0.79
Pain and ketoprofen: what is its role in clinical practice? Reumatismo (2010) 0.79
The recombinant alpha subunit of glutamate synthase: spectroscopic and catalytic properties. Biochemistry (1998) 0.79
Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1. Thromb Haemost (1998) 0.79
Annexin V, a new marker of platelet storage lesion: correlation with dMPV. Transfus Sci (1997) 0.79
Glia-neuron interaction by high-affinity glutamate transporters in neurotransmission. Adv Exp Med Biol (1999) 0.79
[Galactosemia associated with Rogers syndrome in a 10-month-old infant]. Arch Pediatr (2010) 0.79
Plasma thrombomodulin levels increase with the severity of the diabetic retinopathy. Blood Coagul Fibrinolysis (1994) 0.79
Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol (1988) 0.79
[Jacobsen's syndrome, thrombopenia and humoral immunodeficiency]. Arch Pediatr (1998) 0.79
Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII. Arterioscler Thromb Vasc Biol (1996) 0.79
A 13-24 C-terminal peptide related to PF4 accelerates hematopoietic recovery of progenitor cells in vivo in mice treated with 5-fluorouracil. Int J Hematol (1997) 0.79
[Obstructed defecation]. Chirurg (2004) 0.79
Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus. Vasa (1996) 0.78
Frequency of antibodies directed against heparin-platelet factor 4 in patients exposed to heparin through chronic hemodialysis. Thromb Haemost (1996) 0.78